Photo

613-801-1057

...

Ottawa

English

Elizabeth Sterling

Trademark Agent

Elizabeth joined MBM in May 2022. She is a registered Canadian Trademark Agent with over 20 years of experience in trademark portfolio management in Canada and worldwide.

Her practice includes representing clients in trademark clearance, filing, and prosecution, as well as opposition and cancellation proceedings before the Canadian Intellectual Property Office. She is also registered to practice before the United States Patent and Trademark Office.

In her spare time, Elizabeth enjoys playing touch football, spending time with her family, travelling, and taking her dog on nice long walks. She is also a big football fan and loves to travel to different NFL football stadiums to watch games.

Education

  • Registered Trademark Agent (1999)
  • BA French - Carleton University

Professional Involvement

INTA, Committee Member

  • 2016 to 2019 – Leadership Development Committee
  • 2014 to 2015 – Law Firm Committee
  • 2010 to 2013 – Young Practitioners Committee
  • 2006 to 2009 – Trademark Administrators Brunch Committee

IPIC, Fellow Member

  • Program Director of the Intellectual Property Institute of Canada/McGill University Trademarks I Summer Intensive Course in 2004
  • Assistant Program Director of the Intellectual Property Institute of Canada/McGill University Trademarks I Summer Intensive Course in 2003

Practice Area

cb photo 124 561ead1bced0d

DR. POONAM TAUH

Patent Agent


Poonam’s focuses on the drafting and prosecution of pharmaceutical, chemical, biochemical, petrochemical, and polymer patent applications around the world.
MBM read_more_btn

 

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More